| INTRODUC TI ON
Coronary heart disease (CHD) is one of the most common diseases of human life and health and is regarded as a killer that harms the health of middle-aged and elderly people. 1 In western developed countries, CHD has become the leading cause of death in human. Therefore, the prevention and treatment of CHD has become a major public health problem facing all mankind. 2 The main pathological basis is coronary atherosclerosis. Abnormal blood lipids and lipoprotein metabolism are one of the important causes of CHD. 3 The relationship between blood lipids and CHD is highly valued. Epidemiological evidence shows that there is a significant correlation between plasma cholesterol level and CHD occurrence. 4 Elevated cholesterol is a major risk factor for atherosclerosis. Clinical drug research shows that lipid-lowering therapy can stabilize or even reduce plaque and reduce the incidence of cardiovascular events. Gene-level studies have also shown that the LDL receptor mutation can lead to familial hypercholesterolemia, and the level of LDL-C increases significantly, which can increase or advance the occurrence of atherosclerosis and CHD. 
| MATERIAL S AND ME THODS

| Study participants
| Inclusion and exclusion criteria for cases
Patients with CHD and fully conscious and well oriented with person and place were included, and patients with previous revascularization, liver cirrhosis, and end-stage renal diseases were excluded.
| Inclusion and exclusion criteria for controls
Controls with no evidence of CHD and fully conscious and well oriented with person and place were included, and individuals with CHD family history and cancers were excluded.
| DNA extraction and genotyping
Genomic DNA was extracted from 200 μL whole blood according to the manufacturer's protocol (QIAamp blood kit, Qiagen, Germany).
Genotyping was assessed using the SNaPshot method in keeping with the manufacturer's protocol. Twenty duplicate samples were genotyped for assessing the quality of genotype. 
| Statistical analyses
| RE SULTS
| Population characteristics and genotype distributions
There were no differences between the two groups in age and sex.
Clinical baseline characteristics between the two groups are shown in Table 1 . The genotype distributions of three SNPs of ABCA1 gene are shown in Table 2 . The chi-square test showed that there was no SNP deviated from the Hardy-Weinberg equilibrium.
| Association between rs2230806 and susceptibility to CHD
As shown in Table 3 , there was a significant association be- 
| Association between rs4149313 and susceptibility to CHD
As shown in Table 4 , there was a significant association between 
| Association between rs9282541 and susceptibility to CHD
As shown in Table 5 
| D ISCUSS I ON
ABCA1 is expressed in various tissues and organs, and the function of ABCA1 is not similar in different organ tissues. 15 The decrease in ABCA1 expression in the local part of the vessel wall is related to the deposition of lipid in the vessel wall and the vascularization of atherosclerosis. 16 The expression at the fork or bend is significantly lower than the vertical. SNPs are DNA sequence polymorphisms caused by mutations at the genomic nucleotide level, including single base transformations, transversions, and single base deletions and insertions. 17, 18 The susceptibility may be related to race, genetic, environmental, or other factors such as age, sex, diet, and smoking. In normal persons and CHD patients, the most common way of ABCA1 gene mutation is single nucleotide polymorphism. 20, 21 In this study, a total of 484 hospitalized CHD patients and 488 age-and sex-matched controls were investigated the associations between three SNPs rs2230806 (R219K), rs4149313 TA B L E 4 Association between rs4149313 and susceptibility to coronary heart disease (CHD) 
